Last reviewed · How we verify
Hydrofluoroalkane beclomethasone metred dose inhaler
At a glance
| Generic name | Hydrofluoroalkane beclomethasone metred dose inhaler |
|---|---|
| Also known as | Qvar® |
| Sponsor | Research in Real-Life Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
- Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management
- Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: